BioMS Medical named Biotech Company of the Year
Company to receive Gold Leaf Award from BIOTECanada at BIO 2008
"This award recognizes the Canadian biotech company that has distinguished itself from its peers with strong overall performance as a company, demonstrated leadership and significant achievement," said Peter Brenders, President and CEO of BIOTECanada. "BioMS Medical represents these qualities and is recognized as a leader in Canadian biotech."
"We are honored to have received this prestigious award from BIOTECanada," said Kevin Giese, President and CEO of BioMS Medical. "In 2007 we achieved many significant milestones as we advanced our lead drug for MS, MBP8298 (dirucotide). This award recognizes the significant efforts made by the dedicated employees at BioMS and the great progress we've made."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.